Stage IIA Prostate Cancer Completed Phase 2 Trials for Docetaxel (DB01248)

IndicationStatusPhase
DBCOND0028878 (Stage IIA Prostate Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01882985Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer PatientsTreatment